Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio-Food is a publicly traded investment company based in Israel that focuses on the food-tech and biotechnology sectors, specifically targeting the "Future of Food." The fund identifies and invests in high-potential startups developing innovative solutions in alternative proteins, cell-based meat, and sustainable food production. Notable portfolio companies include Steakholder Foods (formerly MeaTech 3D) and BlueTree Technologies, which specialize in 3D bioprinting and sugar reduction, respectively. Bio-Food provides capital and strategic support to help its portfolio companies scale from research and development to commercialization. As one of the first publicly traded vehicles of its kind, it offers investors exposure to the rapidly growing cellular agriculture and sustainable nutrition markets. The company is listed on the Tel Aviv Stock Exchange under the symbol BIOF.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio-Food Investment Fund.